testing guidelines

News

NCCN Biomarker Guideline Adherence Linked With Decreased Mortality in NSCLC

06/16/2020

Adherence to the National Comprehensive Cancer Network (NCCN) guideline for biomarker testing for non-squamous advanced non-small cell lung cancer (NSCLC) is associated with decreased risk of mortality, according to a recent...

Adherence to the National...

06/16/2020

Journal of Clinical Pathways

Guideline Updates

Consensus Recommendations for Germline Testing in Prostate Cancer

06/15/2020

A session entitled “Implementation of Germline Testing for Prostate Cancer” held at the Philadelphia Prostate Cancer Consensus Conference in 2019 provided novel recommendations for genetic testing. Germline testing...

A...

06/15/2020

Journal of Clinical Pathways

Research in Review

Predicting Survival, Treatment Response in Patients With Follicular Lymphoma

08/14/2017

JCP Editors

A recent study suggests a variable that should be used as a standard outcome measure for clinical trials of patients with follicular lymphoma, published in the British Journal of Hematology (online August 7, 2017;...

A...

08/14/2017

Journal of Clinical Pathways

Research in Review

NSCLC Prognostic Index Considers Personal Characteristics to Better Predict Outcomes

07/26/2017

JCP Editors

The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...

The...

07/26/2017

Journal of Clinical Pathways

Research in Review

Blood Test Predicts Survival Outcomes in Patients With Type of Lung Cancer

07/11/2017

JCP Editors

A blood-based proteomic test offers prognostic information and optimal second-line treatment guidance for patients with squamous cell carcinoma (SCC) of the lung, according to research published in Lung Cancer (July...

A...

07/11/2017

Journal of Clinical Pathways

Research in Review

Prognostic Tools Identify High-Risk Patients With Multiple Myeloma, Predict Survival

06/22/2017

JCP Editors

Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology...

...

06/22/2017

Journal of Clinical Pathways

Research in Review

Recent Breast Cancer HER2 Testing Guideline Update Produces Similar Positivity Rate

06/14/2017

JCP Editors

Updates to the 2013 human epidermal growth factor receptor 2 (HER2) testing guideline in breast cancer did not affect the overall positivity rate or the proportion of patients eligible for targeted therapy, according...

...

06/14/2017

Journal of Clinical Pathways

Research in Review

Panel Highlights Uses of Genomic Testing for Breast Cancer

06/07/2017

JCP Editors

A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...

A...

06/07/2017

Journal of Clinical Pathways

Research in Review

Metastatic Breast Cancer Study Recruits Patients Via Social Media

06/04/2017

JCP Editors

A direct-to-patient approach has allowed the Metastatic Breast Cancer Project (MCBP) research study to identify nearly 3000 patients willing to provide medical records and tumor samples for analysis, according to...

A...

06/04/2017

Journal of Clinical Pathways

Research in Review

New NGS Platform Better Identifies Targetable Genomic Alterations in Metastatic Cancers

05/31/2017

JCP Editors

A new comprehensive next generation sequencing (NGS) platform is more likely than targeted NGS platforms to identify clinically relevant and actionable molecular alterations in metastatic cancers, according to...

A new...

05/31/2017

Journal of Clinical Pathways